Canopy Growth Corp
NASDAQ: CGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
Updated 2026-06-05
Canopy Growth Corp (CGC) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $549.00 | $-26918.00 | 100.00% | -4,903.10% | -4,903.10% |
| 2011 | $4488.00 | $-24068.00 | 100.00% | -436.27% | -536.27% |
| 2012 | $4763.00 | $-21393.00 | — | -449.15% | -449.15% |
| 2013 | $4144.00 | $-64608.00 | 100.00% | -1,559.07% | -1,559.07% |
| 2014 | — | $-932925.00 | — | — | — |
| 2014 | $1.15M | $-8.93M | 36.17% | -588.05% | -779.58% |
| 2015 | $1.90M | $-8.93M | 21.84% | -346.10% | -470.87% |
| 2016 | $12.70M | $-3.50M | 149.51% | -21.65% | -27.53% |
| 2017 | $39.90M | $-7.52M | 97.04% | -35.30% | -18.85% |
| 2018 | $77.95M | $-67.28M | 95.18% | -138.26% | -86.32% |
| 2019 | $226.34M | $-736.28M | 39.29% | -271.81% | -325.30% |
| 2020 | $398.77M | $-1.32B | -7.95% | -418.53% | -331.35% |
| 2021 | $546.65M | $-1.74B | 12.25% | -227.47% | -319.20% |
| 2022 | $475.70M | $-310.04M | -39.40% | -214.17% | -65.18% |
| 2023 | $333.25M | $-3.28B | -19.06% | -789.34% | -983.68% |
| 2024 | $297.15M | $-657.27M | 27.22% | -76.97% | -221.19% |
| 2025 | $269.00M | $-598.12M | 29.56% | -43.55% | -222.35% |
Frequently asked questions
What is Canopy Growth Corp's revenue?
Canopy Growth Corp's trailing twelve-month revenue is $278.39M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is CGC?
In its most recent fiscal year, CGC ran a gross margin of 29.56%, an operating margin of -43.55%, and a net margin of -222.35%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does CGC generate?
CGC produced $-177.03M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is CGC's balance sheet healthy?
CGC holds $113.81M in cash and equivalents against $299.81M in long-term debt, on $487.21M of shareholder equity. That debt is best read against the cash flow the business throws off each year.